Marc Y. Donath is Professor and Head of the Clinic for Endocrinology, Diabetes and Metabolism at the University Hospital of Basel, Switzerland. His research focuses on the mechanisms and therapy of decreased insulin production in type 2 diabetes. He has published several studies supporting the concept that a specific inflammatory process underlies beta cell failure and apoptosis in the pathogenesis of this condition. Beyond his special focus on the beta cell he has shown that IL-6 regulates GLP-1 production and release. Finally, recently Dr. Donath has uncovered a monogenic form of type 1 diabetes. He has widely published in journals including the New England Journal of Medicine, Nature and Cell Journals.